BlackRock Inc. - RANI THERAPEUTICS HLDGS INC ownership

RANI THERAPEUTICS HLDGS INC's ticker is and the CUSIP is 753018100. A total of 29 filers reported holding RANI THERAPEUTICS HLDGS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
BlackRock Inc. ownership history of RANI THERAPEUTICS HLDGS INC
ValueSharesWeighting
Q3 2023$138,293
-47.2%
63,5830.0%0.00%
Q2 2023$261,962
-20.2%
63,5830.0%0.00%
Q1 2023$328,088
-12.5%
63,5830.0%0.00%
Q4 2022$375,140
-80.7%
63,583
-68.7%
0.00%
Q3 2022$1,944,000
-9.0%
202,907
-1.9%
0.00%
Q2 2022$2,137,000
+0.6%
206,832
+31.4%
0.00%
Q1 2022$2,125,000
+13.7%
157,374
+37.7%
0.00%
Q4 2021$1,869,000114,2980.00%
Other shareholders
RANI THERAPEUTICS HLDGS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Nan Fung Group Holdings Ltd 493,584$1,073,5450.87%
Alpha Square Group S LLC 86,946$189,1080.19%
LASRY MARC 62,887$136,7790.14%
Alphabet Inc. 448,492$973,2270.06%
UNITED SERVICES AUTOMOBILE ASSOCIATION 481,300$1,034,7950.03%
ISLAY CAPITAL MANAGEMENT, LLC 9,611$20,9040.02%
Activest Wealth Management 9,800$21,3150.01%
Lafayette Investments 19,893$43,2680.01%
MOTCO 48,129$104,6810.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 51,500$112,0130.00%
View complete list of RANI THERAPEUTICS HLDGS INC shareholders